DK0949923T3 - Stabiliserede farmaceutiske præparater på basis af quinupristin og dalfopristin samt deres fremstilling - Google Patents

Stabiliserede farmaceutiske præparater på basis af quinupristin og dalfopristin samt deres fremstilling

Info

Publication number
DK0949923T3
DK0949923T3 DK97945926T DK97945926T DK0949923T3 DK 0949923 T3 DK0949923 T3 DK 0949923T3 DK 97945926 T DK97945926 T DK 97945926T DK 97945926 T DK97945926 T DK 97945926T DK 0949923 T3 DK0949923 T3 DK 0949923T3
Authority
DK
Denmark
Prior art keywords
dalfopristin
quinupristin
stabilized
preparation
well
Prior art date
Application number
DK97945926T
Other languages
Danish (da)
English (en)
Inventor
Jean-Paul Bounine
Guillaume Conrath
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0949923T3 publication Critical patent/DK0949923T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97945926T 1996-11-19 1997-11-14 Stabiliserede farmaceutiske præparater på basis af quinupristin og dalfopristin samt deres fremstilling DK0949923T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614062A FR2755857B1 (fr) 1996-11-19 1996-11-19 Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
PCT/FR1997/002047 WO1998022107A1 (fr) 1996-11-19 1997-11-14 Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation

Publications (1)

Publication Number Publication Date
DK0949923T3 true DK0949923T3 (da) 2002-12-23

Family

ID=9497744

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97945926T DK0949923T3 (da) 1996-11-19 1997-11-14 Stabiliserede farmaceutiske præparater på basis af quinupristin og dalfopristin samt deres fremstilling

Country Status (45)

Country Link
US (1) US5994338A (es)
EP (1) EP0949923B1 (es)
JP (1) JP4278115B2 (es)
KR (1) KR100530836B1 (es)
CN (1) CN1146417C (es)
AP (1) AP998A (es)
AR (1) AR008695A1 (es)
AT (1) ATE223217T1 (es)
AU (1) AU740291B2 (es)
BG (1) BG63621B1 (es)
BR (1) BR9713087A (es)
CA (1) CA2271095C (es)
CO (1) CO4910113A1 (es)
CZ (1) CZ299913B6 (es)
DE (1) DE69715247T2 (es)
DK (1) DK0949923T3 (es)
DZ (1) DZ2349A1 (es)
EA (1) EA002025B1 (es)
EE (1) EE03668B1 (es)
ES (1) ES2179375T3 (es)
FR (1) FR2755857B1 (es)
HK (1) HK1022832A1 (es)
HR (1) HRP970615B1 (es)
HU (1) HUP9904327A3 (es)
IL (2) IL129607A0 (es)
IN (1) IN187038B (es)
JO (1) JO1992B1 (es)
MA (1) MA26448A1 (es)
MY (1) MY123805A (es)
NO (1) NO992399D0 (es)
NZ (1) NZ334949A (es)
OA (1) OA11047A (es)
PE (1) PE13999A1 (es)
PL (1) PL190164B1 (es)
PT (1) PT949923E (es)
RS (1) RS49608B (es)
SA (1) SA97180645B1 (es)
SK (1) SK284311B6 (es)
TN (1) TNSN97184A1 (es)
TR (1) TR199901096T2 (es)
TW (1) TW474816B (es)
UA (1) UA59376C2 (es)
UY (1) UY24780A1 (es)
WO (1) WO1998022107A1 (es)
ZA (1) ZA9710435B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772272B1 (fr) * 1997-12-16 2000-01-14 Rhone Poulenc Rorer Sa Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
EP1674107B8 (en) * 1998-09-25 2017-01-25 Cubist Pharmaceuticals LLC Use of daptomycin
KR100613136B1 (ko) * 1999-03-03 2006-08-17 일라이 릴리 앤드 캄파니 미셀-형성 계면활성제를 함유하는 에키노칸딘 제약학적조제물
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6119269A (en) * 1999-09-23 2000-09-19 Imler; Jack Fishing vest with removable storage container system
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
FR2812549B1 (fr) * 2000-08-03 2003-03-21 Aventis Pharma Sa Associations dalfopristine/quinupristine avec le cefpirome
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2599036B1 (fr) * 1986-05-22 1988-09-09 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CO4910113A1 (es) 2000-04-24
FR2755857A1 (fr) 1998-05-22
JP4278115B2 (ja) 2009-06-10
MA26448A1 (fr) 2004-12-20
IL129607A0 (en) 2000-02-29
TNSN97184A1 (fr) 2005-03-15
HUP9904327A3 (en) 2002-03-28
UY24780A1 (es) 2001-08-27
SK284311B6 (sk) 2005-01-03
WO1998022107A1 (fr) 1998-05-28
EP0949923B1 (fr) 2002-09-04
BG103412A (en) 2000-06-30
AU5125698A (en) 1998-06-10
NO992399L (no) 1999-05-19
OA11047A (fr) 2003-03-07
SK66099A3 (en) 2000-01-18
FR2755857B1 (fr) 1998-12-24
PT949923E (pt) 2003-01-31
SA97180645B1 (ar) 2005-12-12
UA59376C2 (uk) 2003-09-15
CZ299913B6 (cs) 2008-12-29
CN1233959A (zh) 1999-11-03
HK1022832A1 (en) 2000-08-25
EA002025B1 (ru) 2001-12-24
RS49608B (sr) 2007-06-04
PL190164B1 (pl) 2005-11-30
ATE223217T1 (de) 2002-09-15
DE69715247D1 (de) 2002-10-10
TR199901096T2 (xx) 1999-07-21
ZA9710435B (en) 1998-06-10
ES2179375T3 (es) 2003-01-16
AR008695A1 (es) 2000-02-09
EE9900127A (et) 1999-12-15
NO992399D0 (no) 1999-05-19
BG63621B1 (bg) 2002-07-31
HRP970615A2 (en) 1998-08-31
CZ174899A3 (cs) 1999-08-11
JP2001504475A (ja) 2001-04-03
YU22499A (sh) 2002-03-18
AP998A (en) 2001-08-09
PE13999A1 (es) 1999-05-05
US5994338A (en) 1999-11-30
EA199900479A1 (ru) 2000-02-28
DE69715247T2 (de) 2003-04-30
CN1146417C (zh) 2004-04-21
IN187038B (es) 2001-12-29
IL129607A (en) 2006-08-20
CA2271095A1 (fr) 1998-05-28
KR100530836B1 (ko) 2005-11-23
DZ2349A1 (fr) 2002-12-28
BR9713087A (pt) 2000-03-28
CA2271095C (fr) 2004-08-03
KR20000053343A (ko) 2000-08-25
AU740291B2 (en) 2001-11-01
TW474816B (en) 2002-02-01
EE03668B1 (et) 2002-04-15
EP0949923A1 (fr) 1999-10-20
JO1992B1 (en) 1999-05-15
HUP9904327A2 (hu) 2000-06-28
NZ334949A (en) 2000-12-22
HRP970615B1 (en) 2002-12-31
MY123805A (en) 2006-06-30

Similar Documents

Publication Publication Date Title
NO961160D0 (no) Cykliske forbindelser, deres fremstilling og anvendelse
NO962551D0 (no) Stillassystem
BR9704843A (pt) Hidroxifeniltriazinas
DE69717494T2 (de) Shampoo
DE69829733D1 (de) Sicherheitssystem
DE69801042T2 (de) Sicherheitssystem
FR2732706B1 (fr) Garde-corps d'echafaudage
DK1037652T3 (da) Farmaceutiske præparater baseret på dalfopristin og quinupristin samt deres fremstilling
DK0949923T3 (da) Stabiliserede farmaceutiske præparater på basis af quinupristin og dalfopristin samt deres fremstilling
DE29700962U1 (de) Baugerüstelement
DE59601292D1 (de) Schutzplankenanordnung
DE69714650D1 (de) Geschütztes System gegen Übertemperatur
DE29604226U1 (de) Schutzplankenanordnung
DE29706380U1 (de) Sicherheitssystem
DE29618046U1 (de) Gerüstkonstruktion
KR950003861U (ko) 가드레일
NO975017D0 (no) Bolaformforbindelser inneholdende grycerolhoder, deres fremstilling og anvendelse
KR940024943U (ko) 비계틀용 발판
DE29712941U1 (de) Sicherheitsschraube
DE29622656U1 (de) Sicherheitsschraube
NO963459A (no) Snøbrettsikring
DE9315802U1 (de) Abschalwinkel
KR950033383U (ko) 가드레일
DE29704117U1 (de) Sicherheitssystem
DE29605428U1 (de) Haarwaschmittel